| Literature DB >> 23344203 |
Yongxin Zhao1, Jun Dou, Tao Wu, Haji Akber Aisa.
Abstract
Our previous research showed that standardized extract from the flowers of the Gossypium herbaceam labeled GHE had been used in clinical trials for its beneficial effects on brain functions, particularly in connection with age-related dementia and Alzheimer's disease (AD). The aim of this work was to determine the components of this herb and the individual constituents of GHE. In order to better understand this herb for AD treatment, we investigated the acetylcholinesterase (AChE) inhibition and antioxidant activity of GHE as well as the protective effects to PC12 cells against cytotoxicity induced by tertiary butyl hydroperoxide (tBHP) using in vitro assays. The antioxidant activities were assessed by measuring their capabilities for scavenging 1,1-diphenyl-2-picylhydrazyl (DPPH) and 2-2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) free radical as well as in inhibiting lipid peroxidation. Our data showed that GHE exhibited certain activities against AChE and also is an efficient free radical scavenger, which may be helpful in preventing or alleviating patients suffering from AD.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23344203 PMCID: PMC6269909 DOI: 10.3390/molecules18010951
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1HPLC analysis of the GHE and peak fractions from GHE.
Figure 2Chemical structures of the compounds from GHE.
GHE (μg/mL) needed to inhibit acetylcholinesterase and antioxidant activities by 50%.
| Extracts a | DPPH b | ABTS c | TBARS d | AChE e |
|---|---|---|---|---|
| GHE | 13.28 | 1.12 | 3.57 | 28.09 |
a Mean values of three replicates are given. Mean ± SD, n = 3; b Compared to Vit C (IC50 = 8.9 μg/mL), IC50 for inhibition of DPPH radical formation; c Compared to Vit C (IC50 = 3.1 μg/mL), IC50 for inhibition of ABTS radical formation; d Compared to Vit C (IC50 = 5.2 μg/mL), IC50 for inhibition of peroxidation of lipids, estimated as thiobarbituric acid reactive substances (TBARS); e Compared to Huperzine A (IC50 = 0.0104 μg/mL), IC50 for inhibition of AChE.
Amounts of compound (μM) needed to inhibit acetylcholinesterase and antioxidant activities by 50%.
| Compounds a | DPPH b | ABTS c | TBARS d | AChE e |
|---|---|---|---|---|
| Isorhamnetin-7- | 1.73 | 21.76 | 7.20 | 55.70 |
| Kaempferol | 5.52 | 41.41 | 14.30 | 130.07 |
| Quercetin-3,7-di- | 5.48 | 50.79 | 33.44 | 67.05 |
| Quercetin | 0.84 | 19.62 | 13.11 | 50.99 |
| Quercetin-3′- | 3.75 | 34.7 | 8.90 | 88.57 |
| Isoquercetin | 3.65 | 26.95 | 8.81 | 56.98 |
| Hyperoside | 11.19 | 113.25 | 7.47 | 94.61 |
| Quercimeritin | 3.69 | 24.91 | 6.85 | 52.3 |
a Mean values of three replicates are given. Mean ± SD, n = 3; b Compared to Vit C (IC50 = 15.0 μM), IC50 for inhibition of DPPH radical formation; c Compared to Vit C (IC50 =17.6 μM), IC50 for inhibition of ABTS radical formation; d Compared to Vit C (IC50 = 29.5 μM), IC50 for inhibition of peroxidation of lipids, estimated as thiobarbituric acid reactive substances; e Compared to Huperzine A (IC50 = 0.042 μM), IC50 for inhibition of AChE.
Figure 3Protective effects of compounds and GHE on PC12 cells exposed to tBHP.
Figure 4The extraction and fractionations of Gossypium herbaceam.